Mind Medicine (MNMD) Tops Q3 EPS by 20c

Mind Medicine (NASDAQ: MNMD) reported Q3 EPS of ($0.45), $0.20 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
• Jefferies Downgrades Belimo Holding AG (BEAN:SW) (BLHWF) to Hold